MDM4 and neoplasm: Molecular analysis of the HCC-like component of the tumor, demonstrated a highly unstable hyperdiploid genome and evidence of altered cell cycle control, possibly associated with the MDM4 copy gain (located in 1q32), as well as MAPK signaling pathway activation resulting from the RPS6KA3 variant.